PeterDeLongMD

Pulmonology • Lebanon, NH

Critical Care Medicine

Assistant Professor, Medicine, Geisel School of Medicine

Join to view full profile

Dr. DeLong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. DeLong's full profile

Already have an account?

Office
1 Medical Center Dr
Dhmc Pulmonary Division
Lebanon, NH 03756
Phone+1 603-650-5533
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2003
University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1996

Certifications & Licensure

VT State Medical License 2016 - 2024
OH State Medical License 2016 - 2019
NH State Medical License 2004 - 2018
WV State Medical License 2017 - 2018
NE State Medical License 2016 - 2018
SD State Medical License Active through 2018
WY State Medical License 2016 - 2018
KS State Medical License 2017 - 2018
IA State Medical License 2016 - 2017
MN State Medical License 2016 - 2017
ND State Medical License 2016 - 2017
PA State Medical License 1997 - 2004
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Publications & Presentations

PubMed

1 citations
A case of tracheal and pulmonary blastomycosis presenting as asymptomatic pulmonary nodules.
Harrison N. Agyeman, Devin Lee, William J. Hunckler, Peter DeLong, Samuel A. Lee> ;Medical Mycology Case Reports. 2021 Aug 18
4 citations
A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin.
Anna Biernacka, Konstantinos Linos, Peter A DeLong, Arief A. Suriawinata, Vijayalakshmi Padmanabhan, Xiaoying Liu> ;Cytojournal. 2016 Jan 1
15 citations
Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.
Jonathan D. Marotti, C B S Mary Schwab, Nancy J. McNulty, James R. Rigas, Peter A. DeLong, Vincent A. Memoli, Gregory J. Tsongalis, Vijayalakshmi Padmanabhan> ;Diagnostic Cytopathology. 2013 Jan 1
16 citations
Mechanical ventilation in the management of acute respiratory distress syndrome.
Peter A DeLong, James A. Murray, Christopher K. Cook> ;Seminars in Dialysis. 2006 Nov 1
94 citations
Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy
Daniel H. Sterman, Adriana Recio, Anil Vachani, Jing Sun, Lumei Cheung, Peter DeLong, Kunjlata M. Amin, Leslie A. Litzky, James M. Wilson, Larry R. Kaiser, Steven M. A...> ;Clinical Cancer Research. 2005 Oct 15
94 citations
Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
Peter DeLong, Richard G. Carroll, Adam C. Henry, Tomoyuki Tanaka, Sajjad Ahmad, Michael S. Leibowitz, Daniel H. Sterman, Carl H. June, Steven M. Albelda, Robert H. Von...> ;Cancer Biology & Therapy. 2005 Mar 1
21 citations
Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery.
Tomoyuki Tanaka, Peter DeLong, Kunjlata M. Amin, Adam C. Henry, Robert J. Kruklitis, Veena Kapoor, Larry R. Kaiser, Steven M. Albelda> ;Annals of Surgery. 2005 Jan 1
48 citations
Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Eiji Suzuki, Veena Kapoor, H.-Kam Cheung, Leona E. Ling, Peter DeLong, Larry R. Kaiser, Steven M. Albelda> ;Clinical Cancer Research. 2004 Sep 1
44 citations
Immuno-gene therapy with interferon-β before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma
Robert J. Kruklitis, Sunil Singhal, Peter DeLong, Veena Kapoor, Daniel H. Sterman, Larry R. Kaiser, Steven M. Albelda> ;The Journal of Thoracic and Cardiovascular Surgery. 2004 Jan 1
61 citations
Tumor Necrosis Factor α Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon β
Omar Tliba, Samira Tliba, Chien Da Huang, Rebecca Hoffman, Peter DeLong, Reynold A. Panettieri, Yassine Amrani> ;The Journal of Biological Chemistry. 2003 Dec 12
74 citations
Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.
Peter DeLong, Tomoyuki Tanaka, Robb Kruklitis, Adam C. Henry, Veena Kapoor, Larry R. Kaiser, Daniel H. Sterman, Steven M. Albelda> ;Cancer Research. 2003 Nov 15
12 citations
Differentially Expressed Apoptotic Genes in Early Stage Lung Adenocarcinoma Predicted by Expression Profiling
Sunil Singhal, Kunjlata M. Amin, Robert J. Kruklitis, M. Blair Marshall, John C. Kucharczuk, Peter DeLong, Leslie A. Litzky, Larry R. Kaiser, Steven M. Albelda> ;Cancer Biology & Therapy. 2003 May 4
67 citations
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling.
Sunil Singhal, Kunjlata M. Amin, Robert J. Kruklitis, Peter DeLong, Michael E. Friscia, Leslie A. Litzky, Mary E. Putt, Larry R. Kaiser, Steven M. Albelda> ;Cancer Biology & Therapy. 2003 Mar 20
35 citations
Analysis of the Immunologic Response Generated by Ad.IFN-β During Successful Intraperitoneal Tumor Gene Therapy
Makoto Odaka, Rainer Wiewrodt, Peter DeLong, Tomoyuki Tanaka, Yi Zhang, Larry R. Kaiser, Steven M. Albelda> ;Molecular Therapy. 2002 Aug 1
3 citations
An overview of pulmonary host defense
Peter DeLong, Robert M. Kotloff> ;Seminars in Roentgenology. 2000 Apr 1
Join now to see all

Hospital Affiliations

White River Junction Veterans Affairs Medical CenterWhite River Junction, Vermont